Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspen Technology, Inc.AZPN · Entity 82028 | Director | September 01, 2023 | October 03, 2023 |
| CHECK POINT SOFTWARE TECHNOLOGIES LTDCHKP · Entity 1642 | Director | September 02, 2026 | September 03, 2026 |
| Endo International plcENDP · Entity 124463 | Director | June 09, 2017 | June 13, 2017 |
| Evolent Health, Inc.EVH · Entity 5492 | Director | June 04, 2026 | June 08, 2026 |
| R1 RCM Holdco Inc.NONE · Entity 125898 | Director | June 21, 2022 | June 24, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspen Technology, Inc.
Report date September 01, 2023 · Filed October 03, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,238 |
Reported balance
After 2023-09-01 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-09-01 · Grant · Acquired 1,252 · Balance 2,238 F1: Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units were fully vested on the date of grant. F2: The Restricted Stock Units were received as a grant for no consideration. |
| Common StockSEC Table I · non-derivative | Direct | 3,490 |
Reported balance
After 2023-09-01 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2023-09-01 · Grant · Acquired 1,252 · Balance 3,490 F3: Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units will fully vest on the last day of the fiscal year in which they were granted. The original Form 4 filing for this transaction incorrectly stated that the Restricted Stock Units would vest on the first anniversary of the date of grant. F2: The Restricted Stock Units were received as a grant for no consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units were fully vested on the date of grant.
F2: The Restricted Stock Units were received as a grant for no consideration.
F3: Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units will fully vest on the last day of the fiscal year in which they were granted. The original Form 4 filing for this transaction incorrectly stated that the Restricted Stock Units would vest on the first anniversary of the date of grant.
CHECK POINT SOFTWARE TECHNOLOGIES LTD
Report date September 02, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, NIS 0.01 Per ShareSEC Table I · non-derivative | Direct | 4,236 |
Reported balance
After 2026-09-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-02 · Grant · Acquired 1,120 · Balance 4,236 F1: The Reporting Person was granted by the Issuer 1,120 Restricted Share Units (RSUs) that are scheduled to vest as follows: 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement. F2: Includes 1,853 RSUs that are scheduled to vest as follows: 367 on November 1, 2026, 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, 366 on November 1, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $133.89 · Expires 2033-09-01 | Direct | 5,000 |
Reported balance
After 2026-09-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-02 · Grant · Acquired 5,000 · Balance 5,000 F3: The Reporting Person was granted by the Issuer options to purchase 5,000 Ordinary Shares that are scheduled to vest as follows: 2,500 on March 2, 2027, 1,250 on June 2, 2027, 1,250 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. F4: In addition, there are 35,000 Ordinary Shares underlying options held by the Reporting Person, of which 22,500 are vested as of September 3, 2026, and the remaining 12,500 Ordinary Shares underlying the option will vest as follows: 6,250 options on November 1, 2026, and 6,250 options on November 1, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted by the Issuer 1,120 Restricted Share Units (RSUs) that are scheduled to vest as follows: 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.
F2: Includes 1,853 RSUs that are scheduled to vest as follows: 367 on November 1, 2026, 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, 366 on November 1, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.
F3: The Reporting Person was granted by the Issuer options to purchase 5,000 Ordinary Shares that are scheduled to vest as follows: 2,500 on March 2, 2027, 1,250 on June 2, 2027, 1,250 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date.
F4: In addition, there are 35,000 Ordinary Shares underlying options held by the Reporting Person, of which 22,500 are vested as of September 3, 2026, and the remaining 12,500 Ordinary Shares underlying the option will vest as follows: 6,250 options on November 1, 2026, and 6,250 options on November 1, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on the vesting date.
Endo International plc
Report date June 09, 2017 · Filed June 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 43,719 |
Reported balance
After 2017-06-09 transaction · row 1
1 source rowRow 1 · 2017-06-09 · Grant · Acquired 23,934 · Balance 43,719 F1: These ordinary shares were granted to Ms. Smith on June 9, 2017 in consideration of her services on Endo International plc's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: These ordinary shares were granted to Ms. Smith on June 9, 2017 in consideration of her services on Endo International plc's Board of Directors.
Evolent Health, Inc.
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 64,233 |
Reported balance
After 2026-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 41,096 · Balance 64,233 F1: Represents restricted stock units granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
R1 RCM Holdco Inc.
Report date June 21, 2022 · Filed June 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-06-21 transaction · row 1
1 source rowRow 1 · 2022-06-21 · Disposition to issuer · Disposed 26,505 · Balance 0 F1: On June 21, 2022, pursuant to the Transaction Agreement and Plan of Merger, dated as of January 9, 2022, by and among R1 RCM Holdco Inc. (f/k/a R1 RCM Inc.) (the "Company"), R1 RCM Inc. (f/k/a Project Roadrunner Parent Inc.) ("New R1"), Project Roadrunner Merger Sub Inc. ("R1 Merger Sub"), CoyCo 1, L.P., CoyCo 2, L.P. and certain other parties, R1 Merger Sub was merged with and into the Company, with the Company surviving as a direct, wholly owned subsidiary of New R1 (the "Reorganization"). F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.75 · Expires 2030-05-28 | Direct | 0 |
Reported balance
After 2022-06-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-21 · Disposition to issuer · Disposed 15,407 · Balance 0 F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization. F3: Option was granted under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-06-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-21 · Disposition to issuer · Disposed 6,039 · Balance 0 F4: Each RSU represents a contingent right to receive one share of the Company's common stock. F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization. F5: The RSUs will vest in one annual installment on May 27, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 21, 2022, pursuant to the Transaction Agreement and Plan of Merger, dated as of January 9, 2022, by and among R1 RCM Holdco Inc. (f/k/a R1 RCM Inc.) (the "Company"), R1 RCM Inc. (f/k/a Project Roadrunner Parent Inc.) ("New R1"), Project Roadrunner Merger Sub Inc. ("R1 Merger Sub"), CoyCo 1, L.P., CoyCo 2, L.P. and certain other parties, R1 Merger Sub was merged with and into the Company, with the Company surviving as a direct, wholly owned subsidiary of New R1 (the "Reorganization").
F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.
F3: Option was granted under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.
F4: Each RSU represents a contingent right to receive one share of the Company's common stock.
F5: The RSUs will vest in one annual installment on May 27, 2023.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ASPENTECH Corp
Report date May 16, 2022 · Filed May 18, 2022
Section 16 reporting ended · disclosed 2022-05-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-05-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-05-16 · Disposition to issuer · Disposed 1,211 · Balance 436 F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of the AspenTech common stock (other than certain excluded shares) automatically converted into the right to receive $87.69 in cash (the "Cash Consideration"), plus 0.42 of a validly issued, fully paid and nonassessable share of New AspenTech. Row 2 · 2022-05-16 · Disposition to issuer · Disposed 436 · Balance 0 F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F3: Reflects restricted stock units ("RSUs"). Each unvested RSU outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive an award of RSUs covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (x) the number of shares of AspenTech common stock underlying such AspenTech RSU award and (y) the sum of (i) 0.42 and (ii) the quotient obtained by dividing (xx) $87.69 by (yy) the volume-weighted average price per share of the New AspenTech common stock on Nasdaq during the five trading days after the Effective Time (the sum obtained under clause (y), the "Aspen Equity Award Exchange Ratio"). F4: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $149.38 · Expires 2031-04-20 | Direct | 0 |
Reported balance
After 2022-05-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-16 · Disposition to issuer · Disposed 1,288 · Balance 0 F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F4: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. F6: Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent. F5: One third of the options granted at the exercise price of $149.38 will vest on the first anniversary of the grant and the remainder will vest in eight consecutive quarterly installments on the last business day of the quarter until fully vested (except as otherwise necessary to avoid vesting of a fractional share). |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $129.50 · Expires 2031-08-31 | Direct | 0 |
Reported balance
After 2022-05-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-16 · Disposition to issuer · Disposed 298 · Balance 0 F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F4: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. F6: Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent. F7: The option granted at the exercise price of $129.50 was fully vested on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech.
F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of the AspenTech common stock (other than certain excluded shares) automatically converted into the right to receive $87.69 in cash (the "Cash Consideration"), plus 0.42 of a validly issued, fully paid and nonassessable share of New AspenTech.
F3: Reflects restricted stock units ("RSUs"). Each unvested RSU outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive an award of RSUs covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (x) the number of shares of AspenTech common stock underlying such AspenTech RSU award and (y) the sum of (i) 0.42 and (ii) the quotient obtained by dividing (xx) $87.69 by (yy) the volume-weighted average price per share of the New AspenTech common stock on Nasdaq during the five trading days after the Effective Time (the sum obtained under clause (y), the "Aspen Equity Award Exchange Ratio").
F4: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time.
F5: One third of the options granted at the exercise price of $149.38 will vest on the first anniversary of the grant and the remainder will vest in eight consecutive quarterly installments on the last business day of the quarter until fully vested (except as otherwise necessary to avoid vesting of a fractional share).
F6: Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent.
F7: The option granted at the exercise price of $129.50 was fully vested on the date of grant.
CIRCOR INTERNATIONAL INC
Report date October 18, 2023 · Filed October 18, 2023
Section 16 reporting ended · disclosed 2023-10-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-10-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-10-18 · Exercise / conversion · Acquired 3,780 · Balance 17,491 Row 2 · 2023-10-18 · Disposition to issuer · Disposed 17,491 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger dated June 5, 2023 (as amended on June 26, 2023 by Amendment No. 1 to Agreement and Plan of Merger, as further amended on June 29, 2023 by Amendment No. 2 to Agreement and Plan of Merger, the "Merger Agreement"), by and among CIROCR International, Inc. ("CIRCOR"), Cube BidCo, Inc., a Delaware corporation ("Parent"), and Cube Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent, pursuant to which Cube Merger Sub, Inc. merged with and into CIRCOR, with CIRCOR remaining as the surviving corporation, at the effective time of the Merger (the "Effective Time"), (continued in Footnote 2) F2: each issued and outstanding share of common stock, par value $0.01 per share, of CIRCOR ("Company Common Stock"), immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to $56.00, without interest (the "Merger Consideration"), and as of the Effective Time, all such shares of Company Common Stock are no longer outstanding and were automatically cancelled and cease to exist. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2033-03-17 | Direct | 0 |
Reported balance
After 2023-10-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-10-18 · Exercise / conversion · Disposed 3,780 · Balance 0 F3: The Restricted Stock Units ("RSUs") were granted to the Reporting Person by CIRCOR as part of equity incentive grants made by CIRCOR on March 17, 2023. Pursuant to the Merger Agreement, as of the Effective Time, each unvested RSU vested in full. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger dated June 5, 2023 (as amended on June 26, 2023 by Amendment No. 1 to Agreement and Plan of Merger, as further amended on June 29, 2023 by Amendment No. 2 to Agreement and Plan of Merger, the "Merger Agreement"), by and among CIROCR International, Inc. ("CIRCOR"), Cube BidCo, Inc., a Delaware corporation ("Parent"), and Cube Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent, pursuant to which Cube Merger Sub, Inc. merged with and into CIRCOR, with CIRCOR remaining as the surviving corporation, at the effective time of the Merger (the "Effective Time"), (continued in Footnote 2)
F2: each issued and outstanding share of common stock, par value $0.01 per share, of CIRCOR ("Company Common Stock"), immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to $56.00, without interest (the "Merger Consideration"), and as of the Effective Time, all such shares of Company Common Stock are no longer outstanding and were automatically cancelled and cease to exist.
F3: The Restricted Stock Units ("RSUs") were granted to the Reporting Person by CIRCOR as part of equity incentive grants made by CIRCOR on March 17, 2023. Pursuant to the Merger Agreement, as of the Effective Time, each unvested RSU vested in full.
R1 RCM Inc. /DE
Report date November 19, 2024 · Filed November 19, 2024
Section 16 reporting ended · disclosed 2024-11-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-11-19 transaction · row 1
1 source rowRow 1 · 2024-11-19 · Disposition to issuer · Disposed 62,453 · Balance 0 F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated July 31, 2024, by and among the Issuer, Raven Acquisition Holdings, LLC ("Parent") and Project Raven Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), at the time of the Merger (the "Effective Time") the reported securities were disposed of, with 40,212 shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock"), cancelled and converted into the right to receive $14.30 per share in cash without interest (the "Merger Consideration"). F2: Represents 22,241 shares of Common Stock of the Issuer underlying restricted stock units ("RSUs") of the Issuer which, pursuant to the Merger Agreement, were, at the Effective Time, automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (a) the number of shares of Common Stock subject to such RSUs as of immediately prior to the Effective Time and (b) the Merger Consideration. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-11-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-11-19 · Disposition to issuer · Disposed 15,407 · Balance 0 F3: Each outstanding option to purchase Common Stock ("Options") held by the Reporting Person that was outstanding and unexercised immediately prior to or upon the Effective Time, whether vested or unvested, was, at the Effective Time, automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (a) the number of shares of Common Stock subject to such Option and (b) the amount by which the Merger Consideration exceeds the applicable per share exercise price of such Option, with any Options that have a per share exercise price equal to or exceeding the Merger Consideration being cancelled for no consideration as of the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated July 31, 2024, by and among the Issuer, Raven Acquisition Holdings, LLC ("Parent") and Project Raven Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), at the time of the Merger (the "Effective Time") the reported securities were disposed of, with 40,212 shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock"), cancelled and converted into the right to receive $14.30 per share in cash without interest (the "Merger Consideration").
F2: Represents 22,241 shares of Common Stock of the Issuer underlying restricted stock units ("RSUs") of the Issuer which, pursuant to the Merger Agreement, were, at the Effective Time, automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (a) the number of shares of Common Stock subject to such RSUs as of immediately prior to the Effective Time and (b) the Merger Consideration.
F3: Each outstanding option to purchase Common Stock ("Options") held by the Reporting Person that was outstanding and unexercised immediately prior to or upon the Effective Time, whether vested or unvested, was, at the Effective Time, automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (a) the number of shares of Common Stock subject to such Option and (b) the amount by which the Merger Consideration exceeds the applicable per share exercise price of such Option, with any Options that have a per share exercise price equal to or exceeding the Merger Consideration being cancelled for no consideration as of the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2021 Filed Jun 30, 2021 19:19 UTC | CIRCOR INTERNATIONAL INC CIR · Entity 108922 | Exercise / conversionCommon Stock | 5,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-004602 · primarydocument.xml · nonDerivative · entry 1 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/27/2020 utilizing a fair market value (FMV) of a share of the issuers stock of $13.83. The RSU grant vests in its entirety 13 months from date of grant, at which time the RSUs are received by the Reporting Person on either (i) the vest date or (ii) upon the conclusion of a longer deferral period that the Reporting Person elected in advance. This report reflects the full vesting of the original RSU grant and the acquisition by the Reporting Person of the underlying shares. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 16:12 UTC | ASPENTECH Corp AZPN · Entity 127212 | GrantDirector Stock Option (Right to Buy) · Derivative | 1,288 | $149.38 Strike: $149.38 | $192,401.44 |
DisclosureSEC source: 0001127602-21-014337 · form4.xml · derivative · entry 2 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,288 Underlying: Common Stock · 1,288 shares Expires 2031-04-20 F3 · derivative.exercise_date: One third of the options granted at the exercise price of $149.38 will vest on the first anniversary of the grant and the remainder will vest in eight consecutive quarterly installments on the last business day of the quarter until fully vested (except as otherwise necessary to avoid vesting of a fractional share). Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 16:12 UTC | ASPENTECH Corp AZPN · Entity 127212 | GrantCommon Stock | 653 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014337 · form4.xml · nonDerivative · entry 1 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. One third of the Restricted Stock Units will vest on the first anniversary of the grant date and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested. F2 · price: The Restricted Stock Units were received as a grant for no consideration. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 17:16 UTC | CIRCOR INTERNATIONAL INC CIR · Entity 108922 | GrantRestricted Stock Unit · Derivative | 2,827 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-002348 · primarydocument.xml · derivative · entry 1 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,827 Underlying: Common Stock · 2,827 shares Expires 2031-03-17 F1 · derivative.exercise_date: The grant of Restricted Stock Units (RSUs), reported herein, entitles the Reporting Person to receive shares of the issuer common stock either (i) at the end of a 13 month vesting period or (ii) upon the conclusion of such longer deferral period as the Reporting Person may elect in advance. In either occurrence, (i) or (ii), the RSUs automatically convert into shares of common stock on a one-for-one basis at no conversion cost to the Reporting Person. Read SEC document |
| June 14, 2020 Filed Jun 15, 2020 22:20 UTC | R1 RCM Holdco Inc. RCM · Entity 125898 | Exercise / conversionRestricted Stock Units · Derivative | 11,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-009454 · wf-form4_159225958375557.xml · derivative · entry 2 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,047 Underlying: Common Stock · 11,207 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vested in one annual installment on June 14, 2020. Vested shares were delivered to the reporting person on June 14, 2020. F3 · derivative.expiration_date: The RSUs vested in one annual installment on June 14, 2020. Vested shares were delivered to the reporting person on June 14, 2020. Read SEC document |
| June 14, 2020 Filed Jun 15, 2020 22:20 UTC | R1 RCM Holdco Inc. RCM · Entity 125898 | Exercise / conversionCommon Stock | 11,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-009454 · wf-form4_159225958375557.xml · nonDerivative · entry 1 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On June 14, 2019, the reporting person was granted 11,207 RSUs that were previously reported on Table II of Form 4. Read SEC document |
| May 28, 2020 Filed May 29, 2020 20:29 UTC | R1 RCM Holdco Inc. RCM · Entity 125898 | GrantRestricted Stock Units · Derivative | 6,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-008654 · wf-form4_159078417971168.xml · derivative · entry 2 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,254 Underlying: Common Stock · 6,047 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units will vest in one annual installment on May 28, 2021. Vested shares will be delivered to the reporting person on May 28, 2021. F2 · derivative.expiration_date: The restricted stock units will vest in one annual installment on May 28, 2021. Vested shares will be delivered to the reporting person on May 28, 2021. Read SEC document |
| May 28, 2020 Filed May 29, 2020 20:29 UTC | R1 RCM Holdco Inc. RCM · Entity 125898 | GrantDirector Stock Option (right to buy) · Derivative | 15,407 | $0.00 Strike: $10.75 | $0.00 |
DisclosureSEC source: 0001628280-20-008654 · wf-form4_159078417971168.xml · derivative · entry 1 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,407 Underlying: Common Stock · 15,407 shares Expires 2030-05-28 Read SEC document |
| March 27, 2020 Filed Mar 27, 2020 17:12 UTC | CIRCOR INTERNATIONAL INC CIR · Entity 108922 | GrantRestricted Stock Unit · Derivative | 5,044 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-002739 · primarydocument.xml · derivative · entry 1 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,044 Underlying: Common Stock · 5,044 shares Expires 2030-03-27 F1 · derivative.exercise_date: The grant of Restricted Stock Units (RSUs), reported herein, entitles the Reporting Person to receive shares of the issuer common stock either (i) at the end of a 13 month vesting period or (ii) upon the conclusion of such longer deferral period as the Reporting Person may elect in advance. In either occurrence, (i) or (ii), the RSUs automatically convert into shares of common stock on a one-for-one basis at no conversion cost to the Reporting Person. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 21:41 UTC | R1 RCM Holdco Inc. RCM · Entity 125898 | GrantRestricted Stock Units · Derivative | 11,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-008096 · wf-form4_156089407503090.xml · derivative · entry 1 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,207 Underlying: Common Stock · 11,207 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units will vest in one annual installment on June 14, 2020. Vested shares will be delivered to the reporting person on June 14, 2020. F2 · derivative.expiration_date: The restricted stock units will vest in one annual installment on June 14, 2020. Vested shares will be delivered to the reporting person on June 14, 2020. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 01:43 UTC | Endo International plc ENDP · Entity 124463 | GrantOrdinary Shares | 23,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039333 · doc4.xml · nonDerivative · entry 1 Smith Jill D. · CIK 0001463490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,719 F1 · kind: These ordinary shares were granted to Ms. Smith on June 9, 2017 in consideration of her services on Endo International plc's Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.